Clinical Trials Browser

OTHER × Glioma × pegfilgrastim × Clear all

NCT06528691 2026-02-17

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Phase 2 Recruiting

Glioma, Central Nervous System Neoplasms

NCT00612989 2014-07-16

Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma